ID   LAPC-3
AC   CVCL_4743
SY   LAPC3; Los Angeles Prostate Cancer-3
DR   Wikidata; Q54901925
RX   Patent=US6365797;
RX   PubMed=9095173;
RX   PubMed=10861745;
RX   PubMed=12725112;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1440.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   Patent=US6365797;
RA   Sawyers C.L., Klein K.A., Witte O.N., Reiter R.E.;
RT   "Mice models of human prostate cancer progression.";
RL   Patent number US6365797, 02-Apr-2002.
//
RX   PubMed=9095173; DOI=10.1038/nm0497-402;
RA   Klein K.A., Reiter R.E., Redula J., Moradi H., Zhu X.-L.,
RA   Brothman A.R., Lamb D.J., Marcelli M., Belldegrun A.S., Witte O.N.,
RA   Sawyers C.L.;
RT   "Progression of metastatic human prostate cancer to androgen
RT   independence in immunodeficient SCID mice.";
RL   Nat. Med. 3:402-408(1997).
//
RX   PubMed=10861745; DOI=10.1002/1097-0045(20000601)43:4<263::AID-PROS5>3.0.CO;2-I;
RA   van Weerden W.M., Romijn J.C.;
RT   "Use of nude mouse xenograft models in prostate cancer research.";
RL   Prostate 43:263-271(2000).
//
RX   PubMed=12725112; DOI=10.1385/1-59259-372-0:21;
RA   Russell P.J., Kingsley E.A.;
RT   "Human prostate cancer cell lines.";
RL   Methods Mol. Med. 81:21-39(2003).
//